• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

BMF Biotechnology Launches 3D Printed Organ-On-A-Chip Platform to Accelerate Life Sciences Research

by Jasmine Pennic 05/08/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
BMF Biotechnology Launches 3D Printed Organ-On-A-Chip Platform to Accelerate Life Sciences Research

What You Should Know; 

– Boston Micro Fabrication (BMF) today announced the launch of BMF Biotechnology Inc., a dedicated subsidiary focused on developing and commercializing innovative BioChips – advanced microfluidic platforms that mimic human organs. 

– By leveraging BioChip technology, BMF Biotechnology aims to accelerate breakthroughs in drug development, improve cosmetic safety and efficacy testing, and ultimately, contribute to the development of more effective treatments for patients.

BMF: A Legacy of Precision Microfabrication

BMF has established itself as a leader in high-precision micro-printing solutions for various industries, including medical devices, electronics, and life sciences. Their expertise in creating features with exceptional resolution and dimensional tolerance is a cornerstone of their success.

Expanding Beyond Printing: The Rise of BMF Biotechnology

In late 2022, BMF embarked on a strategic expansion. This initiative included the establishment of the San Diego Research Institute, dedicated to pioneering microfluidic BioChip technology for drug discovery and cosmetic testing. The initial phase of research has yielded highly promising results.

BioChips: A Powerful Platform for Advanced Research

BMF Biotechnology’s BioChips offer a revolutionary approach to studying human health and disease. By meticulously replicating the body’s physiological conditions, these platforms enable researchers to:

  • Investigate biological mechanisms of health and disease
  • Evaluate the safety and efficacy of drugs and cosmetics
  • Predict patient responses to treatment

A key advantage of BioChips is their integrated “vascular-mimetic” network. This intricate system mimics the human body’s blood vessels, allowing for the delivery of nutrients, removal of waste products, and distribution of compounds throughout the entire tissue sample. This innovation has the potential to yield:

  • More precise testing results
  • Enhanced prediction of compound sensitivity compared to traditional 2D cell cultures and animal models

BMF Biotechnology Partner Program: Fostering Collaboration and Innovation

To fully unlock the potential of BioChips, BMF Biotechnology is actively recruiting collaboration partners. The BMF Biotechnology Partner Program provides a framework for joint development and validation of innovative devices and biological models. Industry, research institutions, and academia are all encouraged to reach out and explore potential partnerships.

“Building on success that BMF has had with other self-driven innovations such as the UltraThineer veneers, the launch of BMF Biotechnology Inc. represents a significant leap forward in our ability to harness the potential of 3D BioChip technology,” remarked Dr. Jennifer Sun, Chief Scientific Officer of BMF Biotechnology Inc. “With our innovative technology and approach, we aim to empower researchers with the tools they need to translate scientific discoveries into tangible therapeutic solutions that improve patient outcomes.”
  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Medical 3D Printing

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance

Most-Read

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

CB Insights’ 2026 Digital Health 50 Reveals How Agentic AI Is Becoming the Clinical Provider and Medication Access Engine

Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

M&A: Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

CVS Rebrands Health Services Segment, Launches Model for Retail Pharmacy Reimbursement

CVS Health Formalizes Tax-Free Split-Off to Carve Out CVS Pharmacy by 2028

SAMHSA and ONC Invest $20M in Behavioral Health IT Initiative

ONC Finalizes HTI-5 Deregulatory Rule to Cut $1.55B in Health IT Compliance and Accelerate FHIR APIs

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |